Septalyte Bio Pharma Private Limited - Company Profile

It is a business services private limited company based in Chirayinkeezhu, Kerala, India, established in 2023.
2023 Chirayinkeezhu, Kerala, India Active
Last Updated:
Access Report
About Septalyte Bio Pharma Private Limited

Septalyte Bio Pharma Private Limited, a active private limited company, was established on 28 July 2023 in Chirayinkeezhu, Kerala, India. it holds CIN: U46497KL2023PTC082693. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Vishnu Narayanan Madhavan Pillai (Director), Shiju Karthikeyan Vasanthakumari (Director), Mohammed Rafeek (Managing Director). Its latest AGM occurred on 31 December 2024, with the balance sheet filed on 31 March 2024. It is based at C/O Raveendran Nair M, Lotus Building Sree, Chirayinkeezhu, Kerala, 695601.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U46497KL2023PTC082693

  • Registration Number

    082693

  • Incorporation Date

    28 July 2023

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Ernakulam

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 2 Year, 6 Months
  • Last Filing with ROC 31 Mar 2024
Company report

Septalyte Bio Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Septalyte Bio Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Septalyte Bio Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Vishnu Narayanan Madhavan Pillai Director 28 Jul 2023 Current
Shiju Karthikeyan Vasanthakumari Director 28 Jul 2023 Current
Mohammed Rafeek Managing Director 28 Jul 2023 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Septalyte Bio Pharma.

Enhance accessibility to Septalyte Bio Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Septalyte Bio Pharma revenue growth over time
Septalyte Bio Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Septalyte Bio Pharma?

Unlock access to Septalyte Bio Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Septalyte Bio Pharma?

Unlock and access historical data on people associated with Septalyte Bio Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Septalyte Bio Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Septalyte Bio Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Septalyte Bio Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Septalyte Bio Pharma Private Limited last Annual general meeting of members was held on 31 Dec 2024 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Septalyte Bio Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was completed.

  • Director Appointment

    Progress on Vishnu Narayanan Madhavan Pillai was appointed as a Director was appointed as a Director on 28 Jul 2023 & has been associated with this company since 2 years 6 months . was documented.

  • Director Appointment

    The activity Shiju Karthikeyan Vasanthakumari was appointed as a Director was appointed as a Director on 28 Jul 2023 & has been associated with this company since 2 years 6 months . was completed.

  • Director Appointment

    Mohammed Rafeek was appointed as a Managing Director was appointed as a Managing Director on 28 Jul 2023 & has been associated with this company since 2 years 6 months . was recorded as a recent event.

  • Company Incorporation

    The activity Septalyte Bio Pharma Private Limited was registered on 28 Jul 2023 with Roc Ernakulam & aged 2 years 6 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Septalyte Bio Pharma Private Limited?

The CIN of Septalyte Bio Pharma Private Limited is U46497KL2023PTC082693.

Where is Septalyte Bio Pharma Private Limited headquartered?

Septalyte Bio Pharma Private Limited is headquartered at C/O Raveendran Nair M, Lotus Building Sree, Chirayinkeezhu, Kerala, 695601.

When was Septalyte Bio Pharma Private Limited incorporated?

Septalyte Bio Pharma Private Limited was incorporated on 28 July 2023.

Who are the current directors of Septalyte Bio Pharma Private Limited?

The current directors of Septalyte Bio Pharma Private Limited are

Is Septalyte Bio Pharma Private Limited a listed company?

Septalyte Bio Pharma Private Limited is unlisted.

What is the capital structure of Septalyte Bio Pharma Private Limited?

The authorized capital of Septalyte Bio Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available